Analysts expect the New York-based company to report quarterly earnings at 57 cents per share, down from 63 cents per share ...
Pfizer Inc. (NYSE:PFE) is one of the most undervalued large cap stocks to invest in now. On January 27, Cantor Fitzgerald raised the firm’s price target on Pfizer to $27 from $24 and maintained a ...
Overview: Pfizer stock is trading near $25.86 with moderate upside potential based on the forecast range of up to ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
Pfizer Inc. has a 6% yield and 8.49x P/E with new cancer drugs and GLP-1 therapies to offset 2026-2028 LOE cycles. Read why ...
The 2025-26 Pfizer COVID-19 vaccine is about 57% effective against emergency department/urgent care (ED/UC) visits and 54% ...
Pfizer and BioNTech released more human data Friday indicating the omicron BA.5 boosters perform better than the old Covid shots. Stream NBC 5 for free, 24/7, wherever you are. People older than 55 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results